Health-related quality of life (QoL) and psychological well-being after withdrawal from hormone therapy (HT). A randomised double-blind placebo-controlled trial. - Quality of life after withdrawal from HT

udwig-Maximilians-Universitaet Muenchen0 个研究点开始时间: 2006年9月1日最近更新: 2012年5月29日

适应症

试验速览

暂无简介。

•Women aged 55 to 69:
•- who are on menopausal HT for at least three years
•- who are currently taking Presomen® 0.6mg/ 5mg compositum or Presomen® 28 compositum 0.3 mg/5 mg
•- who have good knowledge of German for filling in the questionnaires
•- who have had a mammography in the last year or will have one before starting intake of medication
•- who have signed the informed consent
•- who intend to continue on HT for at least 6 months
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•- have had hysterectomy
•- who have known, suspected, or history of breast cancer
•- who have history or existing venous thromboembolism
•- who have had previous acute heart disease or stroke
•- who have active or history of liver dysfunction or disease
•- who have known or suspected estrogen-dependent neoplasia (particularly cancer of the endometrium)
•- who have untreated endometrial hyperplasia
•- who have undiagnosed abnormal genital bleeding
•- who have porphyry
•- who have terminal renal insufficiency
•- or who are participating in another clinical trial

发起方

udwig-Maximilians-Universitaet Muenchen